{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:54:27Z","timestamp":1787237667798,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T00:00:00Z","timestamp":1389312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s12640-013-9454-8","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T09:56:36Z","timestamp":1389261396000},"page":"85-98","source":"Crossref","is-referenced-by-count":90,"title":["Antidepressant-like Effect of Tetrahydroisoquinoline Amines in the Animal Model of Depressive Disorder Induced by Repeated Administration of a Low Dose of Reserpine: Behavioral and Neurochemical Studies in the Rat"],"prefix":"10.1007","volume":"26","author":[{"given":"Lucyna","family":"Antkiewicz-Michaluk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"W\u0105sik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Mo\u017cd\u017ce\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Roma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Michaluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"9454_CR1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1471-4159.2001.00391.x","volume":"78","author":"L Antkiewicz-Michaluk","year":"2001","unstructured":"Antkiewicz-Michaluk L, Michaluk J, Mokrosz M, Roma\u0144ska I, Lorenc-Koci E, Otha S, Vetulani J (2001) Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. J Neurochem 78:100\u2013108","journal-title":"J Neurochem"},{"key":"9454_CR2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2006.03756.x","volume":"97","author":"L Antkiewicz-Michaluk","year":"2006","unstructured":"Antkiewicz-Michaluk L, Lazarewicz JW, Patsenka A, Kajta M, Zieminska E, Salinska E, Wasik A, Golembiowska K, Vetulani J (2006) The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity. J Neurochem 97:846\u2013856","journal-title":"J Neurochem"},{"key":"9454_CR3","doi-asserted-by":"crossref","unstructured":"Antkiewicz-Michaluk L, W\u0105sik A, Michaluk J (2014) 1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application. Neurotox Res 25:1\u201312","DOI":"10.1007\/s12640-013-9402-7"},{"key":"9454_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0149-7634(94)00050-B","volume":"19","author":"F Borsini","year":"1995","unstructured":"Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19:377\u2013395","journal-title":"Neurosci Biobehav Rev"},{"key":"9454_CR5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","volume":"94","author":"F Borsini","year":"1988","unstructured":"Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147\u2013160","journal-title":"Psychopharmacology"},{"key":"9454_CR6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jnnp.52.6.724","volume":"52","author":"R Cantello","year":"1989","unstructured":"Cantello R, Aguggia M, Gilli M, Delsedime M, Cutin IC, Riccio A, Mutani R (1989) Major depression in Parkinson\u2019s disease and the mood response to intravenous methylphenidate: possible role of the \u201chedonic\u201d dopamine synapse. J Neurol Neurosurg Psychiatry 52:724\u2013731","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9454_CR7","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","volume":"27","author":"WM Caudle","year":"2007","unstructured":"Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormak AL et al (2007) Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27:8138\u20138148","journal-title":"J Neurosci"},{"key":"9454_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tins.2008.02.010","volume":"31","author":"WM Caudle","year":"2008","unstructured":"Caudle WM, Colebrooke RE, Emson PC, Miller GW (2008) Altered vesicular dopamine storage in Parkinson\u2019s disease: a premature demise. Trends Neurosci 31:303\u2013308","journal-title":"Trends Neurosci"},{"key":"9454_CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","volume":"287","author":"V Chan-Palay","year":"1989","unstructured":"Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression. J Comp Neurol 287:373\u2013392","journal-title":"J Comp Neurol"},{"key":"9454_CR10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0028-3908(87)90110-9","volume":"26","author":"FC Colpaert","year":"1987","unstructured":"Colpaert FC (1987) Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rats. Neuropharmacology 26:1431\u20131440","journal-title":"Neuropharmacology"},{"key":"9454_CR11","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","volume":"295","author":"JF Cryan","year":"2000","unstructured":"Cryan JF, Lucki I (2000) Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther 295:1120\u20131126","journal-title":"J Pharmacol Exp Ther"},{"key":"9454_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","volume":"182","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Page ME, Lucki I (2005) Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacol 182:335\u2013344","journal-title":"Psychopharmacol"},{"key":"9454_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","volume":"73","author":"MJ Detke","year":"1996","unstructured":"Detke MJ, Lucki I (1996) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43\u201346","journal-title":"Behav Brain Res"},{"key":"9454_CR14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotoninergic and noradrenergic antidepressants. Psychopharmacol (Berl). 121:66\u201372","journal-title":"Psychopharmacol (Berl)."},{"key":"9454_CR15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","volume":"28","author":"AS Elhwuegi","year":"2004","unstructured":"Elhwuegi AS (2004) Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28:435\u2013451","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9454_CR16","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.pnpbp.2008.05.004","volume":"32","author":"VS Fernandes","year":"2008","unstructured":"Fernandes VS, Ribeiro AM, Melo TG, Godinho M, Barbosa FF, Medeiros DS (2008) Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 32:1479\u20131483","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9454_CR17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbr.2012.03.008","volume":"231","author":"VS Fernandes","year":"2012","unstructured":"Fernandes VS, Santos JR, Leao A, Medeiros A, Melo TG, Izidio GS, Cabral A, Ribeiro RA et al (2012) Repeated treatment with a low dose of reserpine as a progressive model of Parkinson\u2019s disease. Behav Brain Res 231:154\u2013163","journal-title":"Behav Brain Res"},{"key":"9454_CR18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","volume":"103","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Riederer P (1996) Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103:987\u20131041","journal-title":"J Neural Transm"},{"key":"9454_CR19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633\u2013643","journal-title":"Mol Pharmacol"},{"key":"9454_CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0006-2952(79)90108-4","volume":"28","author":"GL Grunewald","year":"1979","unstructured":"Grunewald GL, Reitz TJ, Ruth JA, Vollmer S, Eiden LE, Ruthedge CO (1979) Inhibition of neuronal uptake of 3H-biogenic amines rat cerebral cortex by partially and fully saturated derivatives of imipramine and desipramine. The importance of the aromatic ring in adrenergic amines\u2014Part 3. Biochem Pharmacol 28:417\u2013421","journal-title":"Biochem Pharmacol"},{"key":"9454_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0024-3205(79)90275-3","volume":"24","author":"JI Javaid","year":"1979","unstructured":"Javaid JI, Perel JM, Davis JM (1979) Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain. Life Sci 24:21\u201328","journal-title":"Life Sci"},{"key":"9454_CR22","first-page":"1216","volume-title":"Principles of neural science","author":"ER Kandel","year":"2000","unstructured":"Kandel ER (2000) Disorders of mood: depression, mania, and anxiety disorders. In: Kandel ER (ed) Principles of neural science, 4th edn. McGraw-Hill Companies, New York, pp 1216\u20131217","edition":"4"},{"key":"9454_CR23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.clinbiochem.2009.06.006","volume":"42","author":"J Kodydkova","year":"2009","unstructured":"Kodydkova J, Vavrova L, Zeman M, Jirak R, Macasek J, Stankova B, Tvrzicka E, Zak A (2009) Antioxidative enzymes and increased oxidative stress in depressive women. Clin Biochem 42:1368\u20131374","journal-title":"Clin Biochem"},{"key":"9454_CR24","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1046\/j.1471-4159.1995.65062633.x","volume":"65","author":"Y Kotake","year":"1995","unstructured":"Kotake Y, Tasaki Y, Makino Y, Otha S, Hirobe M (1995) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem 65:2633\u20132638","journal-title":"J Neurochem"},{"key":"9454_CR25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(92)90425-C","volume":"70","author":"Y Liu","year":"1992","unstructured":"Liu Y, Peter D, Roghani A (1992) cDNA that suppresses MPP toxicity encodes a vesicular amine transporter. Cell 70:539\u2013551","journal-title":"Cell"},{"key":"9454_CR26","first-page":"287","volume":"29","author":"M Maes","year":"2008","unstructured":"Maes M (2008) The cytokine hypothesis of depression: inflammation, oxidative and nitrosative stress and leaky gut as a new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 29:287\u2013291","journal-title":"Neuro Endocrinol Lett"},{"key":"9454_CR27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in NeuroPsychopharmacol Biol Psychiatry 35:676\u2013692","journal-title":"Progress in NeuroPsychopharmacol Biol Psychiatry"},{"key":"9454_CR28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/bms.1200190706","volume":"19","author":"Y Makino","year":"1990","unstructured":"Makino Y, Tasaki Y, Ohta S, Hirobe M (1990) Confirmation of the enantiomers of 1-methyl-1,2,3,4-tetrahydroisoquinoline in the mouse brain and foods applying gas chromatography\/mass spectrometry with negative ion chemical ionization. Biomed Environ Mass Spectrom 19:415\u2013419","journal-title":"Biomed Environ Mass Spectrom"},{"key":"9454_CR29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","volume":"39","author":"R Mayeux","year":"1984","unstructured":"Mayeux R, Stern Y, Cote L, Williams JB (1984) Altered serotonin metabolism in depressed patients with Parkinson\u2019s disease. Neurology 39:642\u2013646","journal-title":"Neurology"},{"key":"9454_CR30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0006-2952(98)00142-7","volume":"56","author":"KS McNaught","year":"1998","unstructured":"McNaught KS, Carrupt PA, Altomare C, Cellamare S et al (1998) Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson\u2019s disease. Biochem Pharmacol 56:921\u2013933","journal-title":"Biochem Pharmacol"},{"key":"9454_CR31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","volume":"20","author":"GW Miller","year":"1999","unstructured":"Miller GW, Gainetdinov RR, Levey AI, Caron MG (1999) Dopamine transporters and neuronal injury. Trends Pharmacol Sci 20:424\u2013429","journal-title":"Trends Pharmacol Sci"},{"key":"9454_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2008.01.014","volume":"583","author":"F Murray","year":"2008","unstructured":"Murray F, Smith DW, Huston PH (2008) Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviors in mice. Eur J Pharmacol 583:115\u2013127","journal-title":"Eur J Pharmacol"},{"key":"9454_CR33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","volume":"146","author":"Y Nagakura","year":"2009","unstructured":"Nagakura Y, Oe T, Aoki T, Matsuoka N (2009) Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain 146:26\u201333","journal-title":"Pain"},{"key":"9454_CR34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000118535","volume":"33","author":"M Naoi","year":"1993","unstructured":"Naoi M, Maruyama W (1993) Type B monoamine oxidase and neurotoxins. Eur Neurol 33:31\u201337","journal-title":"Eur Neurol"},{"key":"9454_CR35","first-page":"727","volume":"56","author":"A Patsenka","year":"2004","unstructured":"Patsenka A, Antkiewicz-Michaluk L (2004) Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds\u20141,2,3,4-tetrahydroisoquinoline alkaloids. Pol J Pharmacol 56:727\u2013734","journal-title":"Pol J Pharmacol"},{"key":"9454_CR36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair test in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379\u2013391","journal-title":"Eur J Pharmacol"},{"key":"9454_CR37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/026988110401800305","volume":"18","author":"MO Rojas-Corrales","year":"2004","unstructured":"Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA (2004) Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J Psychopharmacol 18:404\u2013411","journal-title":"J Psychopharmacol"},{"key":"9454_CR38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-3-0348-9315-2_10","volume":"29","author":"H Rommelspacher","year":"1985","unstructured":"Rommelspacher H, Susilo R (1985) Tetrahydroisoquinolines and \u03b2-carbolines: putative natural substances in plants and mammals. Prog Drug Res 29:415\u2013459 Birkh\u00e4user Verlag Basel","journal-title":"Prog Drug Res"},{"key":"9454_CR39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1096\/fasebj.9.8.7768351","volume":"9","author":"TP Singer","year":"1995","unstructured":"Singer TP, Ramsay RR (1995) Flavoprotein structure and mechanism 2. Monoamine oxidases: old friends hold many surprises. FASEB J 9:605\u2013610","journal-title":"FASEB J"},{"key":"9454_CR40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-5793(93)80539-7","volume":"318","author":"CK Surratt","year":"1993","unstructured":"Surratt CK, Persico AM, Yang DX (1993) A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPs. FEBS Lett 318:325\u2013330","journal-title":"FEBS Lett"},{"key":"9454_CR41","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1471-4159.1991.tb06407.x","volume":"57","author":"Y Tasaki","year":"1991","unstructured":"Tasaki Y, Makino Y, Ohta S, Hirobe M (1991) 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J Neurochem 57:1940\u20131943","journal-title":"J Neurochem"},{"key":"9454_CR42","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","volume":"29","author":"TN Taylor","year":"2009","unstructured":"Taylor TN, Caudle WM, Shepherd KR (2009) Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci 29:8103\u20138113","journal-title":"J Neurosci"},{"key":"9454_CR43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ana.410430503","volume":"43","author":"GR Uhl","year":"1998","unstructured":"Uhl GR (1998) Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson\u2019s disease. Ann Neurol 43:555\u2013560","journal-title":"Ann Neurol"},{"key":"9454_CR44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-2999(00)00565-3","volume":"405","author":"J Vetulani","year":"2000","unstructured":"Vetulani J, Nalepa I (2000) Antidepressants: past, present and future. Eur J Pharmacol 405:351\u2013363","journal-title":"Eur J Pharmacol"},{"key":"9454_CR45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12640-009-9001-9","volume":"15","author":"A W\u0105sik","year":"2009","unstructured":"W\u0105sik A, Roma\u0144ska I, Antkiewicz-Michaluk L (2009) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies. Neurotox Res 15:15\u201323","journal-title":"Neurotox Res"},{"key":"9454_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2012.11.063","volume":"700","author":"A W\u0105sik","year":"2013","unstructured":"W\u0105sik A, Mo\u017cd\u017ce\u0144 E, Roma\u0144ska I, Michaluk J, Antkiewicz-Michaluk L (2013) Antidepressant-like activity of an endogenous amine, 1-methyl-1,2,3,4-tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: a comparison with the classical antidepressant, imipramine. Eur J Pharmacol 700:110\u2013117","journal-title":"Eur J Pharmacol"},{"key":"9454_CR48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","volume":"581","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Ma R, Shen J, Su H, Xing D, Du L (2008) A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 581:113\u2013120","journal-title":"Eur J Pharmacol"},{"key":"9454_CR49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","volume":"13","author":"T Ziemssen","year":"2007","unstructured":"Ziemssen T, Reichmann H (2007) Non-motor dysfunction in Parkinson\u2019s disease. Parkinsonism Relat Disord 13:323\u2013332","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-013-9454-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-013-9454-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-013-9454-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:25:34Z","timestamp":1746087934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-013-9454-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,10]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["9454"],"URL":"https:\/\/doi.org\/10.1007\/s12640-013-9454-8","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,10]]}}}